These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 28766120)
21. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group]. Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M; Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896 [TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875 [TBL] [Abstract][Full Text] [Related]
23. Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen. Oschlies I; Kohler CW; Szczepanowski M; Koch K; Gontarewicz A; Metze D; Hillen U; Richter J; Spang R; Klapper W J Invest Dermatol; 2017 Nov; 137(11):2450-2453. PubMed ID: 28684330 [No Abstract] [Full Text] [Related]
24. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008 [TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines. Pedretti S; Urpis M; Leali C; Borghetti P; Baushi L; Sala R; Tucci A; Greco D; Pasinetti N; Triggiani L; Rossi G; Calzavara-Pinton P; Magrini SM; Buglione M Tumori; 2018 Oct; 104(5):394-400. PubMed ID: 28218382 [TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment. Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705 [TBL] [Abstract][Full Text] [Related]
27. What is new about primary cutaneous B cell lymphomas. Blanchard M; Hoetzenecker W; Blanchard G; Guenova E Ital J Dermatol Venerol; 2023 Jun; 158(3):205-216. PubMed ID: 37278499 [TBL] [Abstract][Full Text] [Related]
28. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals. Jaffe ES Mod Pathol; 2020 Jan; 33(Suppl 1):96-106. PubMed ID: 31653979 [TBL] [Abstract][Full Text] [Related]
29. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373 [TBL] [Abstract][Full Text] [Related]
30. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ; Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836 [TBL] [Abstract][Full Text] [Related]
37. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry. Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409 [TBL] [Abstract][Full Text] [Related]
38. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475 [TBL] [Abstract][Full Text] [Related]
39. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma. Vermeesch J; Ramirez J; Lafond A Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]